<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03199183</url>
  </required_header>
  <id_info>
    <org_study_id>2016-ZX43</org_study_id>
    <nct_id>NCT03199183</nct_id>
  </id_info>
  <brief_title>Registration Study of Takayasu's Arteritis in China</brief_title>
  <acronym>TA-China</acronym>
  <official_title>Registration Study of Takayasu's Arteritis in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China National Center for Cardiovascular Diseases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China National Center for Cardiovascular Diseases</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Takayasu arteritis(TA) is a chronic progressive vasculitis predominantly affecting the aorta
      and its major branches. The demographic, clinical and prognostic features of Takayasu
      arteritis in China remains in uncertainties. Investigators aim to setup a national
      registration study for Takayasu arteritis, to observe the prevalence, clinical
      manifestations, natural history, survival, progression, diagnostic and therapeutic methods of
      the disease in China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: The study aims to investigate the demographic, clinical and prognostic features
      and to draw the diagnostic and therapeutic algorithm of Takayasu arteritis in China.

      Study Type: A national, multicenter, observational, ambispective cohort study.

      Study Design: The cardinal contents of this registry study are as follows:

        1. Select representative clinical centers through typical sampling methods and train the
           local investigators in basic knowledge of Takayasu arteritis. Introduce the Electronic
           Data Capture System and train in completing case report forms.

        2. Collect demographic, clinical, imaging, laboratory, diagnostic and therapeutic
           information of Takayasu arteritis patients hospitalized from Jan 1st 2015 to now. Build
           a baseline database of Takayasu arteritis patients.

        3. Recruit new diagnosed Takayasu arteritis patients in future 2 years from July 1st 2017
           or till reaching a total of 1067 registered patients.

        4. Gather the 3-month, 6-month, 1-year follow up information including general, clinical,
           therapeutic, prognostic data of all recruits and build up the follow-up database.

        5. Establish bio-bank for serum/plasma, urine, stool, tissues or cells.

      Data management, quality control and statistic analysis: Electronic Data Capture System has
      been built and the investigators will manage and analyze data in align with key indicators.
      The investigators have invited professional statistic analysts to assist analyzing data and a
      third party to supervise data quality.

      Ethics: The Ethics Committee of Fuwai Hospital approved this study and following ethical
      supports from participating centers are required. Informed consents before patient enrollment
      are required.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>prevalence rate</measure>
    <time_frame>1 year</time_frame>
    <description>the percentage of Takayasu arteritis patients among general population (estimated) during one-year period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>survival rate or mortality rate</measure>
    <time_frame>1 year, at 3-month interval</time_frame>
    <description>the percentage of alive or dead recruits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rehospitalization rate</measure>
    <time_frame>1 year, at 3-month interval</time_frame>
    <description>the percentage of readmission to hospitals or centers</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1067</enrollment>
  <condition>Takayasu Arteritis</condition>
  <arm_group>
    <arm_group_label>Takayasu arteritis</arm_group_label>
    <description>All recruited Takayasu arteritis patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>PET-CT</intervention_name>
    <description>PET-CT will be proceed on the basis of clinical status and aspiration of individual patient. The imaging results will be analysed by professional radiologists.</description>
    <arm_group_label>Takayasu arteritis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>laboratory biomarker analysis</intervention_name>
    <description>Screening of potential biomarkers related to Takayasu arteritis and verification tests will be operated.</description>
    <arm_group_label>Takayasu arteritis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>genetic sequencing</intervention_name>
    <description>Genetic sequencing results will be analysed to identify susceptible alleles or single nucleotide polymorphisms of Takayasu arteritis.</description>
    <arm_group_label>Takayasu arteritis</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      All participants will have samples with DNA taken for laboratory biomarker analysis or
      genetic sequencing.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Takayasu arteritis patients diagnosed in all participant centers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All of the patients diagnosed in participating clinical centers with Takayasu arteritis
        fulfilled the American College of Rheumatology 1990 criteria for the classification of
        Takayasu arteritis or the 1996 revised diagnostic criteria for Takayasu arteritis from
        Ishikawa K by Sharma BK et al. Patients highly suspected as Takayasu arteritis but
        uncertain in local centers can apply for assistant diagnosis of senior medical
        institutions.

        Exclusion Criteria:

          1. Manifestations caused by other diseases: atherosclerosis, fibromuscular dysplasia,
             Bechet's disease, giant cell arteritis, congenital vascular malformation, syphilis and
             other infections resulting in vasculitis.

          2. Pregnant women and lactating women.

          3. None indications for Takayasu arteritis from ultrasound, computed tomographic
             angiography, magnetic resonance angiography, digital subtraction angiography.

          4. Absence of patient consents or dropout during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huimin Zhang, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese Academy of Medical Sciences, Fuwai Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jun Cai, MD.PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese Academy of Medical Sciences, Fuwai Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luyun Fan, MD.</last_name>
    <phone>01088398249</phone>
    <email>katevan@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Huimin Zhang, MD.</last_name>
    <phone>01088398249</phone>
    <email>fwzhanghuimin@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chinese Academy of Medical Sciences Fuwai Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>Xichen District</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Huimin Zhang, MD.</last_name>
      <phone>010-88398249</phone>
      <email>fwzhanghuimin@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Jun Cai, MD.PhD.</last_name>
      <phone>010-88322165</phone>
      <email>caijun@fuwaihospital.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol. 1988 Oct;12(4):964-72.</citation>
    <PMID>2901440</PMID>
  </reference>
  <reference>
    <citation>Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990 Aug;33(8):1129-34.</citation>
    <PMID>1975175</PMID>
  </reference>
  <reference>
    <citation>Yang L, Zhang H, Jiang X, Zou Y, Qin F, Song L, Guan T, Wu H, Xu L, Liu Y, Zhou X, Bian J, Hui R, Zheng D. Clinical manifestations and longterm outcome for patients with Takayasu arteritis in China. J Rheumatol. 2014 Dec;41(12):2439-46. doi: 10.3899/jrheum.140664. Epub 2014 Oct 1.</citation>
    <PMID>25274886</PMID>
  </reference>
  <reference>
    <citation>Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996 Aug;54 Suppl:S141-7. Review.</citation>
    <PMID>9119516</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2017</study_first_submitted>
  <study_first_submitted_qc>June 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2017</study_first_posted>
  <last_update_submitted>June 23, 2017</last_update_submitted>
  <last_update_submitted_qc>June 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Takayasu Arteritis</keyword>
  <keyword>registry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteritis</mesh_term>
    <mesh_term>Takayasu Arteritis</mesh_term>
    <mesh_term>Aortic Arch Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Consent for sharing of non identifiable study data for regulatory authorities.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

